Unichem Labs soars 8% as Q3 net up 10 folds
The company had posted a profit of Rs 2.06 crore for the October-December quarter of the previous financial year, 2014-15.25-01-2016
25-01-2016
Results Press Release
Unichem Laboratories Ltd has submitted to BSE a copy of Results Press Release for the period ended December 31, 2015.23-01-2016
Outcome of Board Meeting
Unichem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 23, 2016, inter alia, has allotted 17025 Equity Shares having a face value of Rs. 2/- each pursuant to exercise of options by eligible employees under the Employees Stock Option Scheme 2008.23-01-2016
Financial Results & Limited Review Report for Dec 31, 2015 (Standalone)
Unichem Laboratories Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report (Standalone) for the period ended December 31, 2015.23-01-2016
Conference Call
Unichem Laboratories Ltd has informed BSE regarding a conference call on the financial results for the quarter and nine months ended December 31, 2015.22-01-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Unichem Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.13-01-2016
Board Intimation for Results & Closure of Trading Window
Unichem Laboratories Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on January 23, 2016, to inter alia consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2015.Further, in terms of the Company's Code of Conduct to Regulate, Conduct. Monitor and Report Trading by Insiders, formulated and adopted under the Securities and...07-01-2016
Authorised KMPs to determine materiality of events/information
Unichem Laboratories Ltd has informed BSE regarding "Authorised Key Managerial Personnel to determine materiality of events/information".09-12-2015
Unichem Lab gains on USFDA nod for hypertension drug
The stock moved higher by 5% to Rs 291, bouncing back 7% from intra-day low on the BSE.08-12-2015
Unichem Laboratories receives Final ANDA approval from USFDA for Irbesartan Tablets USP
Unichem Laboratories Ltd has informed BSE regarding a Press Release dated December 08, 2015 titled "Unichem Laboratories receives Final ANDA approval from USFDA for Irbesartan Tablets USP".08-12-2015